While England is Making PrEP Dramatically Cheaper, American Men Still Can’t Afford It
Thanks to a court ruling in the UK, a cheaper generic version of PrEP could be available in the future, but in the United States, only 4% of men who have sex with men are using the drug — and cost is a big culprit. PrEP has shown itself…
#BreakThePatent: How HIV activists are going after Gilead’s PrEP patent
Activists are pushing the government to “march in” and break the pharma giant’s Truvada patent. Their promise is tantalizing: end the HIV epidemic without a vaccine. But how? In an op-ed published this week in The New York Times, two prominent HIV activists and a physician argue “the solution comes in a…